Cypress Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,323
Closed -$362K 106
2024
Q3
$362K Buy
2,323
+760
+49% +$123K 0.09% 91
2024
Q2
$253K Buy
+1,563
New +$235K 0.07% 95
2021
Q1
Sell
-2,125
Closed -$212K 139
2020
Q4
$212K Hold
2,125
0.06% 141
2020
Q3
$233K Hold
2,125
0.07% 125
2020
Q2
$225K Buy
+2,125
New +$219K 0.08% 123
2018
Q1
Sell
-3,088
Closed -$214K 177
2017
Q4
$214K Sell
3,088
-225
-7% -$15.2K 0.05% 178
2017
Q3
$224K Hold
3,313
0.05% 184
2017
Q2
$226K Sell
3,313
-2,225
-40% -$145K 0.05% 183
2017
Q1
$345K Sell
5,538
-1,550
-22% -$90.2K 0.07% 169
2016
Q4
$387K Sell
7,088
-525
-7% -$29.8K 0.07% 159
2016
Q3
$500K Sell
7,613
-1,822
-19% -$119K 0.1% 137
2016
Q2
$570K Sell
9,435
-51,263
-84% -$2.98M 0.11% 137
2016
Q1
$3.42M Sell
60,698
-1,137
-2% -$68.3K 0.69% 50
2015
Q4
$4.2M Sell
61,835
-665
-1% -$43.6K 0.84% 38
2015
Q3
$3.98M Buy
62,500
+95
+0.2% +$6.25K 0.84% 45
2015
Q2
$3.98M Buy
62,405
+1,095
+2% +$75K 0.75% 46
2015
Q1
$4.2M Buy
+61,310
New +$4.26M 0.78% 43

Other funds holding AZN